Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial

1. Ravassa, S.
2. Trippel, T.
3. Bach, D.
4. Bachran, D.
5. González, A.
6. López, B.
7. Wachter, R.
8. Hasenfuss, G.
9. Delles, C.
10. Dominiczak, A.F.
11. Pieske, B.
12. Díez, J.
13. Edelmann, F.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1002/EJHF.1194 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus